BlackRock, Inc. 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
BlackRock Inc. BLK |
3,263,907 6.000% |
1,958,403 (+150.01%) |
Filing |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Olema Pharmaceuticals, Inc. OLMA |
BlackRock Inc. BLK |
1,305,504 3.200% |
-992,660 (-43.19%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
BlackRock Inc. BLK |
2,298,164 5.700% |
2,298,164 (New Position) |
Filing |